April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
A Pathogenic Role of the Wnt Pathway in Diabetic Retinopathy
Author Affiliations & Notes
  • Y. Chen
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • Y. Hu
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • T. Zhou
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • K. K. Zhou
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • R. Mott
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • G. Gao
    Department of Biochemistry, Zhongshan University, Guangzhou, China
  • M. Wu
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • M. Boulton
    Anatomy and Cell Biology, University of Florida, Gainesville, Florida
  • T. J. Lyons
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • J.-X. Ma
    Cell Biology, Medicine, Oklahoma University, Oklahoma City, Oklahoma
  • Footnotes
    Commercial Relationships  Y. Chen, None; Y. Hu, None; T. Zhou, None; K.K. Zhou, None; R. Mott, None; G. Gao, None; M. Wu, None; M. Boulton, None; T.J. Lyons, None; J.-X. Ma, None.
  • Footnotes
    Support  NIH grants EY012231, EY015650, and P20RR024215, a grant from OCAST and a grant from ADA.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4980. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Chen, Y. Hu, T. Zhou, K. K. Zhou, R. Mott, G. Gao, M. Wu, M. Boulton, T. J. Lyons, J.-X. Ma; A Pathogenic Role of the Wnt Pathway in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4980.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The Wnt pathway is known to regulate multiple biological and pathological processes. The purpose of this study was to investigate whether Wnt signaling plays a pathogenic role in diabetic retinopathy (DR).

Methods: : Retinal levels of β-catenin, a key effector of the Wnt pathway, were compared between diabetic human donors with non-proliferative retinopathy (NPDR) and non-diabetic donors, and between DR models including streptozotocin-induced diabetic rats, Akita mice and rats with oxygen-induced retinopathy (OIR) and their respective non-diabetic controls. Retinal inflammation was evaluated by retinal vascular permeability and inflammatory factor levels. Retinal neovascularization (NV) was examined by fluorescein angiography and counting pre-retinal vascular cells.

Results: : Elevated levels and nuclear translocation of β-catenin were observed in the retinas from human donors with NPDR and in all of the three DR animal models. Retinal levels of low-density lipoprotein receptor-related proteins 5 and 6, co-receptors of Wnts, were also elevated in the diabetic and OIR models. In cultured endothelial cells, high glucose induced nuclear translocation of β-catenin, which was attenuated by an antioxidant, suggesting that oxidative stress is the direct cause of the Wnt pathway activation in diabetes. DKK1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation and retinal NV in the DR models. DKK1 also blocked the ROS generation induced by high glucose, suggesting that the Wnt pathway contributes to the oxidative stress in diabetes.

Conclusions: : The Wnt pathway is activated in DR and plays a pathogenic role in retinal inflammation and retinal NV. The Wnt pathway activation represents a new pathogenic mechanism of DR and thus, represents a new therapeutic target.

Keywords: diabetes • vascular endothelial growth factor • retinopathy of prematurity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×